FGF23 and chronic kidney disease: In addition, it seems plausible that in the setting of CKD, the cleavage of FGF23 is attenuated or its capacity overwhelmed, leading to extremely high levels of biologically active FGF23 in end stage kidney disease, most likely contributing to uremic toxicity.